Disclosed are oxo-hydroquinazolines of formula I that are useful as selective TSHR agonists. The compounds may be used for detecting or treating thyroid cancer, or treating a bone degenerative disorder.
公开了具有下式I的氧羟基
喹唑啉,其作为选择性
TSHR激动剂是有用的。这些化合物可用于检测或治疗甲状腺癌,或治疗骨质退行性疾病。